ABSTRACT -Spinal cord injury (SCI) is
Introduction and aim of the guidelines
It is estimated that 40,000 individuals in the UK are living following traumatic spinal cord injury (SCI). 1, 2 The prevalence of other conditions causing SCI, for example inflammatory, neoplastic and infective conditions is currently unknown.
When a patent with SCI is admitted to a general hospital setting for a procedure or intercurrent illness, hospital staff are required to manage both the acute illness and the SCI. They need to be aware that lack of pain or touch sensation below the level of the lesion in a person with complete SCI may confound diagnosis, but in addition many people with SCI:
• are maintained on finely tuned management routines, eg pressure sore prevention or bladder/bowel management which, if disturbed, can take weeks to re-establish.
• require an accessible environment, their usual equipment, eg wheelchair and/or nursing staff familiar with SCI to optimise their management during intercurrent illness. Quality Requirement 11 of the National Service Framework for Long-term (Neurological) Conditions emphasises the importance of listening to the person and their family who are often expert in the management of the condition, and of maintaining close contact with the individual's regular team/specialist spinal injuries centres. 3 These guidelines aim to assist in their assessment and management to avoid the common problems of hospital-acquired morbidity in this potentially vulnerable group of people. Details of the guideline development and methodology are given in the full guideline. 4 
Pathophysiological consequences of spinal cord injury
Pathophysiological consequences of SCI that physicians should particularly be aware of are listed in Box 1. Autonomic dysreflexia is a relatively uncommon, but potentially life-threatening, problem for which people with SCI at the level of T6 and above are at risk. Its features are listed in Box 2 and a flow chart for management in Fig 1. 
Implications for implementation
The implications for implementation of these guidelines are primarily those of staff eduation and awareness. Telephone advice is available from SCI centres and local specialist neurorehabilitation can often offer useful practical support. More detailed guidance,
Clinical Medicine -pulse, respiratory rate, and temperature -oximetry -vital capacity (VC) and forced expiratory volume in 1 second (FEV1) (if possible).
• for perioperative patients, or other increased risk of chest pathology:
-arterial blood gases and chest X-ray
• skin and pressure ulcer risk assessment:
-with grading of any existing ulcers
• baseline calf and thigh measurements to allow early detection of DVT • urinary assessment including:
-review of voiding method and pattern -24-hour voided volume chart -post-void residual volume (by catheter or bladder scan), if voiding on urge or by reflex -urinary microscopy and culture, if symptoms or signs of local or systemic infection continued
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• assessment of bowel care needs:
-plan of management developed within 24 hours of admission
• nutritional assessment including:
-dietary intake -weight and biochemistry (albumin, haemoglobin, haematinics)
• full neurological assessment as soon as possible to identify patient's baseline, thereby ensuring early detection of any deterioration
• musculoskeletal assessment including spasticity assessment, assessment of joint range of movement and pain -calf and thigh measurements to allow early detection of DVT -skin and pressure areas.
• frequent assessment, as appropriate, of:
-respiratory function including: -symptom check and examination -pulse, respiratory rate, temperature -oximetry, VC and FEV1 (if unstable or at risk). -bowel function, including:
-stool consistency -frequency of bowel action and interventions -neurological impairments, if there is concern that this is changing.
C Management of patients with SCI 1 All patients with SCI admitted to hospital should: C
• be discussed (following their consent) with their SCI centre for information and advice as indicated • have a written care plan which includes the following: -management of autonomic dysreflexia for patients at risk (T5-6 or above) (Fig 1) -respiratory management to prevent or treat chest complications, developed in conjunction with a chest -or neurophysiotherapist. This may include:
-clearing of airway secretions -assisted coughing, suctioning (be aware of the risk of bradycardia induced by suction) -re-expansion of affected lung including deep breathing, positioning, intermittent positive pressure ventilation, bi-phasic positive airway pressure, bronchoscopy with lavage and medications -commence thromboembolic prophylaxis if immobilised with bed rest or admitted for medical illness or -surgery (as per hospital policy) including:
-thromboembolism deterrent stockings unless contraindicated -low molecular weight heparin* -preventative measures to avoid pressure sores, or full pressure relief in the presence of existing ulcers -adequate nutrition provided to meet their individual needs including calories, protein, micronutrients -and fluids. Aggressive nutritional support if:
-dietary intake is inadequate, or the individual is nutritionally compromised continued
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-continuation of normal bowel management programme, unless there is reason to change, including -diet, use of laxatives and bowel stimulants -digital stimulation and manual evacuation as required -continuation of normal bladder management programme, unless there is reason to change. If an -indwelling urethral catheter has been necessary during the admission it should be removed as soon as -is possible and the patient's usual bladder care regimen re-established -management of spasticity and avoidance of secondary musculoskeletal complications including:
-splinting ,stretching and passive movement, if appropriate -regular standing programme, if appropriate. The following should be in place prior to discharge:
• all required arrangements for transport, care and equipment needs etc • full reports from all professionals involved with their care • appropriate transport arrangements made for any future outpatient or review appointments.
*Patients with established SCI do not require long-term thromboprophylaxis unless there is a history of thromboembolic disease. Therefore normal prophylaxis should be given for the illness/procedure, according to local policy and can be stopped as usual when medically well. q This is an acute, life-threatening condition of which all physicians should be aware.
Bladder
The great majority of individuals with SCI also have impairments in bladder function:
q detrusor-sphincter dyssynergia -muscle incordination which leads to the bladder voiding against a closed sphincter resulting in incomplete emptying. It can cause over filling and backpressure on the kidneys if not proactively managed q urinary tract infections -often undetected due to lack of typical symptoms.
Bowel
Sensory and motor control of the ano-rectum is impaired. Individuals are unable to feel the need to evacuate the bowel, or control the process of defaecation:
q high risk of constipation, due to slow stool transit -especially where morphine or codeine-related drugs or anticholinergics are used q without intervention, individuals will be incontinent and chronically constipated, with secondary complications, including the risk of autonomic dysreflexia (T6 and above).
including practical tools for management, are given in the full guideline. 4 Box 2. Typical features of autonomic dysreflexia. 
